SOC
SOC is a pharmaceutical drug with 53 clinical trials. Currently 18 active trials ongoing. Historical success rate of 85.2%.
Success Metrics
Based on 23 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
20
Mid Stage
10
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
82.1%
23 of 28 finished
17.9%
5 ended early
18
trials recruiting
53
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Safety and Efficacy Evaluation of Serplulimab Plus Chemo in SCLC Transformed From EGFR-mutated NSCLC After Treatment
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
A Study in Pediatric Participants Aged ≥2 to <12 Years With a Suspected or Confirmed Bacterial Infection or Receiving Prophylaxis Antibiotics
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
Clinical Trials (53)
Safety and Efficacy Evaluation of Serplulimab Plus Chemo in SCLC Transformed From EGFR-mutated NSCLC After Treatment
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
A Study in Pediatric Participants Aged ≥2 to <12 Years With a Suspected or Confirmed Bacterial Infection or Receiving Prophylaxis Antibiotics
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer
Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care
DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years Old
Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease
Non-invasive Vagal Neurostimulation (nVNS) for Traumatic Brain Injury (TBI)-Induced Acute Respiratory Distress
Effect of Telitacicept on Antibody Titers in Primary APS Patients
A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy
REFLECTION: A Clinical Practice Learning Program for Galleri®
A Study to Learn About Effects of Living With COVID-19 and the Use of the Medicines Nirmatrelvir-Ritonavir in Treating COVID-19.
UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML
Post Stroke Ambulation Recovery Using Robotic Exoskeletons
Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV Iron
Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension
Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS)
Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 53